|
IMMUNOGENIC CORONAVIRUS FUSION PROTEINS AND RELATED METHODS
IMMUNOGENIC CORONAVIRUS FUSION PROTEINS AND RELATED METHODS
Researchers at Stanford have developed fusion proteins as a novel vaccine strategy for SARS-CoV2.
As the causative force of the COVID-19 pandemic, SARS-CoV2 caused massive sustained morbidity, mortality, and societal disruption worldwide. Though COVID-19 has largely transitioned from...
Published: 10/6/2023
|
Inventor(s): Peter Kim, Natalia Friedland, Mrinmoy Sanyal, Payton Weidenbacher
Keywords(s): Coronavirus, COVID, COVID-19, Infectious Disease, Vaccine
Category(s): Technology Classifications > Biology
|
|
CORONAVIRUS NEUTRALIZING COMPOSITIONS AND ASSOCIATED METHODS
CORONAVIRUS NEUTRALIZING COMPOSITIONS AND ASSOCIATED METHODS
Researchers at CZ Biohub SF and Stanford have developed unique fusion proteins that have broad therapeutic benefits for the treatment of infection by existing and future coronaviruses.
Coronaviruses cause human illness ranging from the common cold to more severe diseases. They are large,...
Published: 7/27/2023
|
Inventor(s): Payton Weidenbacher, Peter Kim, Eric Waltari
Keywords(s): Antibody, Broad-Spectrum, Coronavirus, Fusion Protein, Highly-Conserved, Inhibitor, Neutralizing, Receptor, Variant
Category(s): Technology Classifications > Biology
|
|
A STRATEGY FOR CREATING VACCINES TO ELICIT ANTIBODIES TARGETING A SPECIFIC EPITOPE
A STRATEGY FOR CREATING VACCINES TO ELICIT ANTIBODIES TARGETING A SPECIFIC EPITOPE
Researchers at Stanford, funded in part by the Chan Zuckerberg Biohub, have developed PMD (Protect, Modify, Deprotect), an immunofocusing strategy that can be used in vaccine development for the generation of antibodies targeting a specific epitope.
Vaccine development...
Published: 3/17/2023
|
Inventor(s): Payton Weidenbacher, Peter Kim
Keywords(s): Antibody, Epitope Shield, Immunofocusing, mAb, Monoclonal Antibody, Vaccine
Category(s): Technology Classifications > Biology
|
